Together we shape the future of HPB

Together, We Make First-Time Success Possible ​

Advancing Hepato-Pancreato-Biliary Endoscopy for First-Time Success

Progress in endoscopy and gastroenterology has transformed Hepato-Pancreato-Biliary (HPB) care into a dynamic, multifaceted field that spans diverse diseases, patient needs, and multidisciplinary collaboration.

As specialists in minimally invasive solutions, with decades of leadership in endoscopic innovation and deep experience working alongside gastroenterologists, we understand that HPB disorders require complex diagnostic and therapeutic interventions across Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Ultrasound (EUS), and advanced endoscopic imaging systems.

In HPB, every decision matters. Whether routine or complex clinical challenges, you need trusted, reliable solutions that support accurate diagnosis and quality care.

At Boston Scientific, we offer a comprehensive range of minimally invasive technologies built on proven designs and refined through clinical experience.


Our Comprehensive HPB Portfolio

Our portfolio supports first-time procedural success1-3, and shorter procedure times4-7, helping healthcare systems deliver care more efficiently and sustainably,2, 8-10, while delivering meaningful improvements in patient outcomes.4-7

Endoscopic Retrograde Cholangiopancreatography (ERCP)

Endoscopic Retrograde Cholangiopancreatography (ERCP) remains essential in the management of biliary and pancreatic diseases, yet it still carries a notable risk of complications, with up to 1 in 6 patients requiring unplanned hospitalisation.11,12

Our wide and established global ERCP portfolio is designed to support controlled cannulation, enable efficient therapy, and help manage complex cases with confidence. Grounded in a proven legacy of innovation, our versatile solutions aim to support consistent, first-time procedural success.

   

Access in ERCP

Access in ERCP

Reliable, controlled ductal access is the foundation of every successful ERCP procedure. Explore our dedicated portfolio of biliary access solutions designed to support clinicians across the full range of therapeutic needs.

Explore our ERCP Access Solutions

Access in ERCP

Stone Management

From straightforward extraction to complex lithotripsy, our stone management portfolio supports the entire bile duct stone clearance pathway with solutions built for confident, efficient performance.

See our full Stone Management portfolio

Access in ERCP

Stricture Management

Our evidence-based portfolio addresses both benign and malignant biliary strictures, encompassing stenting, dilation, and radiofrequency ablation technologies.

Discover our Stricture Management solutions


Endoscopic Ultrasound (EUS)

Variability in EUS operator expertise, procedural complexity, and access to advanced tools can limit consistent diagnostic yield and procedural confidence.13

Strengthen EUS delivery through diagnostic EUS needles and therapeutic application with LAMS (Lumen Apposing Metal Stents). All are designed for minimally invasive intervention in complex EUS cases.

Access in ERCP

EUS Diagnostic

Unlock the power of precision with our EUS Diagnostic Solutions. Our innovative technologies are designed to enhance diagnostic accuracy, providing healthcare professionals with the tools they need to deliver exceptional patient care.

Find out more about EUS Diagnostic

Access in ERCP

EUS Therapeutic

Our therapeutic EUS solutions are designed to support minimally invasive intervention across a broad range of complex gastrointestinal conditions, enabling precise and effective drainage in challenging EUS cases.

Find out more about EUS Therapeutic


Imaging Systems

Different procedures demand different solutions. Our single-use imaging portfolio is designed to support consistent performance across varied clinical needs.

Access in ERCP

Cholangioscopes

Our cholangioscopy solutions enable you to confidently diagnose and treat biliary conditions in a single, minimally invasive procedure within the biliary tree.

Explore our Cholangioscopy portfolio

Duodenoscopes

Duodenoscopes

Designed to provide consistent performance, streamline workflows, and eliminate or reduce reprocessing downtime, our duodenoscope solutions are built with efficiency and reliability in mind, supporting seamless procedures and optimising time in the endoscopy suite.

Learn about our Duodenoscope

Choledochoscopes

Choledochoscopes

Our choledochoscope solutions deliver high-resolution imaging and procedural flexibility designed to support physician preference, patient needs, and efficient intraoperative workflows.

Find out more about our Choledochoscopes

   


One Partner. Multiple Solutions.

Rising clinical demand, increasing operational pressures, and the need to meet sustainability targets are key challenges facing modern endoscopy services. At Boston Scientific, we combine advanced technology, tailored programmes, and specialist expertise to support you in delivering high-quality care within a complex and evolving environment.

Professional Education

Professional Education

Evidence‑based education developed with clinicians and learning specialists to help teams build and advance procedural expertise.

commercial Solutions

Commercial Solutions

Operational and financial solutions: designed to improve financial visibility and predictability, reduce budget pressure, and optimise operations, supporting clinical priorities, flexibility, and sustainable departmental growth.

Environmental Sustainability

Environmental Sustainability

Advancing environmental performance and progress toward net-zero while improving efficiency across the endoscopy supply chain and maintaining clinical and operational excellence.


Connect with us:

Connect with our team to access the support, resources, and information you need to stay informed and make the most of our endoscopy solutions.


References

1. Shah RJ, et al. Endoscopy. 2017;49(7):651-8

2. Deprez PH, et al. Endoscopy. 2018;50(2):109-18.

3. Brewer Gutierrez OI, et al. Clin Gastroenterol Hepatol. 2018;16(6):918-26.e1.

4. Draganov PV, et al. Dig Dis Sci. 2010;55(2):510-5.

5. Maceček J, et al. Gastroenterol Hepatol. 2021;75:200-6.

6. Liang H, et al. J Cancer Ther. 2017;6(11).

7. Buxbaum J et al. Gastrointest Endosc. 2018;87(4):1050-60.

8. Li ZQ, et al. J Minim Access Surg. 2020;16(3):206-14.

9. Gao YC, et al. Medicine (Baltimore). 2017;96(37):e7925

10. Lyu Y, et al. Surg Endosc. 2019;33(10):3275-86.

11. ASGE Standards of Practice Committee, et al. Gastrointest Endosc. 2017;85(1):32-47.

12. Barakat M, et al. Gastroenterology. 2025;169(2):230-243.e8.

13. Lee LS, et al. World J Gastrointest Endosc. 2017;9(9):399-415.

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.